December 2025

December's Top Stories: FDA panel votes against J&J device | Trump's health | CPT code updates | Cardiologist dies after arrest ()
New strategies for the cath lab | The first surgery of its kind | CMS considers coverage for asymptomatic TAVR | PAD & diabetes ()
FDA confirms recall for heart device | Updates in AI reimbursement | Cardiologists urge Trump administration to kill proposal ()
Severe AS more commonly missed in women | FDA clears Abbott delivery device | Repairing 2 leaky heart valves at once ()
AI has transformed TAVR care—and the best is yet to come | The impact of improved reimbursement | Cardiology's biggest trend ()
FDA announces new recalls for Johnson & Johnson & Medtronic | Reviewing a busy year in healthcare advocacy ()
FDA approves Abbott PFA system | New cath lab strategies | Bleeding reversal agent pulled from market | MiniMed files for IPO ()
Payment updates for cardiologists | A new heart pump for kids | Philips makes a move | Financial news from Medtronic, Edwards ()
Cardiology’s biggest trend | FDA approves drug for genetic heart disease | Workforce issues | PAD & diabetes | New PFA registry ()
Top 10 most popular cardiology video interviews this past month ()
Week in Review: Philips to acquire SpectraWAVE | Cardiologist dies | CMS may cover asymptomatic TAVR | Reimbursement for RDN ()
FDA panel votes against J&J device | Progress for oral heart failure drug | New recalls announced ()
FDA clears Abbott device | Employment trends in cardiology | New ACC/AHA guidelines | AI flags hard-to-detect heart disease ()
CPT code updates | Pope meets with cardiologists | Philips makes a move | ASC growth | Catheters recalled | Workforce woes ()
RDN reimbursement | Cardiologist's victims file lawsuit | First-in-human heart surgery | Societies must adapt | TAVR or SAVR? ()
Cardiologist's actions at heart of new lawsuit against online dating apps ()
CMS considers covering TAVR in asymptomatic patients | Cardiologist dies after arrest | The risks of various cancer treatments ()
News Alert: CMS considers covering TAVR in asymptomatic patients ()
Key reimbursement updates | Philips to acquire SpectraWAVE | New CCTA software from Siemens Healthineers ()
Philips to acquire imaging company | FDA approves nasal spray for heart patients | New device makes debut | AS in women vs. men ()
News Alert: Philips to acquire SpectraWAVE ()
New recalls for troubled heart devices | More procedures headed to ASCs | FDA clears next-gen mapping software | Heartflow's AI ()
Week in Review: Pope meets with cardiologists | CPT code updates | Workforce woes | Doc reportedly fired over vaccine panel ()
Key EP trends | CMS update seen as 'tremendous victory' | FDA clears ‘thermometer of the future’ | Drones deliver AEDs ()
CCTA adoption expected to take off | FDA clears new heart device | Cardiologist reportedly fired over role with vaccine panel ()
'Beer belly' linked to multiple risks | Trump's heart health | Abbott's safety warning | Semaglutide & stroke prevention ()
Q&A: Key trends in pediatric electrophysiology | Is a common word giving patients the wrong idea? | HHS urged to kill proposal ()
CPT code changes on the way for interventional cardiology | IVL & diabetes | M-TEER in patients with smaller mitral valve areas ()
Historic hospital pauses transplant program | FDA announces new recall | A heart pump for children | ECMO pioneer remembered ()
Workforce woes in cardiology | A new heart pump for children | Diabetes & sudden cardiac death ()
IVC filter recalled | Growing interest in endovascular procedures | FDA clears new robotic system | PE thrombectomy on the rise ()
Edwards Lifesciences looks ahead | FDA chief's vaccine claims | Pope Leo meets with cardiologists | TAVR & vulnerable patients ()
Week in Review: Doctors still unsure about Trump’s health | New recalls | FDA panel votes against J&J device | AI for TAVR ()
AI transforming TAVR | Catheters recalled | Historic hospital pauses heart transplant program | Ablations at ASCs: Expert advice ()
FDA panel votes against HF device | Left-heart access system cleared | Medtronic insulin pump now sold with Abbott sensors ()
Surgical patches recalled | 3-in-1 TAVR guidewire impresses | Stem cell company acquires cardiology practices | SCAI & CRT unite ()
TAVR Highlights: AI transforming care | Early treatment linked to key benefits | 'Highly concerning' Medicare trends ()
AI & TAVR: The best is yet to come | Doctors unsure about Trump’s health after 'weird' memo | New CT software announced at RSNA ()
November's Top Stories: New CMS policies | CCTA's impact | Gene-editing therapy impresses | Robotic aortic valve replacement ()
White House statement examines Trump’s heart health | 'Highly concerning' TAVR trends | 'Beer belly' linked to multiple risks ()
A key update to how cardiologists get paid | FDA shares catheter warning | Cardiac ablations in ASCs | Multiple new recalls ()
Catheters recalled over health risks | Improved reimbursement | Medtronic recalls software | Cardiology: Empowering or stifling? ()